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Abstract
Accumulation of mast cells can be causally related to several allergic inflammations. Stem cell factor (SCF) as a mast cell
chemotaxin induces mast cell migration. To clarify a new effect of Pyeongwee-San extract (KMP6, a drug for indigestion) for
the treatment of allergy, we investigated the effects of KMP6 on SCF-induced migration of rat peritoneal mast cells (RPMCs).
A molecular docking simulation showed that hesperidin, a major component of KMP6, controls the SCF and c-kit binding by
interaction with the active site of the c-kit. KMP6 and hesperidin significantly inhibited SCF-induced migration of RPMCs
(P,0.05). The ability of the SCF to enhance morphological alteration and F-actin formation was also abolished by treatment
with KMP6 or hesperidin. KMP6 and hesperidin inhibited SCF-induced p38 MAPK activation. In addition, SCF-induced
inflammatory cytokine production was significantly inhibited by treatment with KMP6 or hesperidin (P,0.05). Our results
show for the first time that KMP6 potently regulates SCF-induced migration, p38 MAPK activation and inflammatory
cytokines production through hindrance of SCF and c-kit binding in RPMCs. Such modulation may have functional
consequences during KMP6 treatment, especially mast cell-mediated allergic inflammation disorders.
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Introduction
The mast cell is one of the major effector cells in inflammatory
reactions and can be found in most tissues throughout the body
[1]. An accumulation of mast cells has been described in several
inflammatory conditions, e.g., atopic dermatitis [1], allergic
rhinitis [2], asthma [3], and rheumatoid arthritis [4]. Such
symptoms require directed migration of mature mast cells or their
precursors. Several recent reports provide support for the
hypothesis that growth factor and chemokine-mediated chemo-
taxis of mast cells within tissues can be an important mechanism
for a rapid increase in the number of mast cells at sites of
inflammation [1,5].
Stem cell factor (SCF) is a crucial growth factor in mast cell
biology. It regulates such diverse cellular functions as proliferation,
differentiation, survival, adhesion, and release of inflammatory
mediators [6]. SCF acts as a mast cell chemotaxin [1].
Furthermore, injection of SCF into the skin causes mast cell
hyperplasia [7], indicating that SCF may be important for the
recruitment of mast cell in vivo. SCF also induces the pro-
inflammatory mediators including histamine, tumor necrosis
factor (TNF)-a, interleukin (IL)-1b, IL-6, IL-8, and IL-16 from
mast cells [8]. Mast cell-derived TNF-a contributes to allergic
reactions through production of an intracellular adhesion molecule
(ICAM)-1 [9].
The mitogen-activated protein kinase (MAPK) family comprises
at least 6 subsets: extracellular signal-regulated kinase (ERK)1/
ERK2, p38 kinase (p38, p38-b,- c, and -d), c-JUN NH2-terminal
protein kinase (JNK), ERK5, ERK6, and ERK7 [10]. MAPKs are
believed to play a pivotal role in cell proliferation, apoptosis,
differentiation, cytoskeleton remodeling, and cell cycle [11,12].
SCF similarly activates all MAP kinase [13]. Previously,
Sundstrom et al. [14] reported that SCF induced a rapid and
transient activation of ERK and p38 in mouse mast cells.
Inhibition of p38 activity by SB203580 was paralleled with a
marked reduction of migration toward SCF, whereas the effect of
the ERK inhibitor was less pronounced.
Pyeongwee-San extract (KMP6) is used for the treatment of
gastrointestinal disorders such as inappetance, abdominal disten-
sion, borborygmus, diarrhea induced by gastric atony, gastric
dilatation, and gastrointestinal catarrh. Many studies have
reported that gastrointestinal disorders are closely associated with
skin allergic diseases [15,16]. In this study, we investigated the
SCF-dependent effects of KMP6 and its component, hesperidin on
migration of rat peritoneal mast cells (RPMCs).
Methods
Ethics statement
All protocols were approved by the institutional animal care and
use committee of Kyung Hee University [Protocol Number.
KHUASP (SE)-09].
Materials
Avidin peroxidase, metrizamide, SB203580, dimethyl sulfoxide
(DMSO), 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT), and 29-AZINO-bis (3-ethylbenzithiazoline-6-
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Sigma (St. Louis, MO, USA). Recombinant murine SCF,
recombinant murine TNF-a and ICAM-1, purified anti-TNF-a
and ICAM-1, and biotin-conjugated anti- TNF-a and ICAM-1
were purchased from R&D system (Minneapolis, MN, USA). Fetal
bovine serum, a-minimum essential medium (MEM), ampicillin,
and streptomycin were purchased from Gibco BRL (Grand Island,
NY, USA). Antibody against p38 and phosphorylated-p38 were
purchased from Santa Cruz Biotechnology (Santa cruz, CA, USA).
N-7-nitrobenz-2-oxa-1, 3-diazol-4-phallacidin (NBD-phallacidin)
was purchased from Molecular probes (Eugene, Oregon, USA).
Preparation of KMP6
KMP6 was provided by the Korea Medi Inc. (Seoul, Republic
of Korea). We obtained the Pyeongwee-San, HS-PS (an over-the-
counter drug for indigestion), from Han Kook Shin Yak
pharmaceutical Co. (Nonsan, Republic of Korea) to compare
with KMP6. KMP6 is composed of Atractylodes japonica Koidzumi
(13.3 g), Magnolia officinale Rehder et Wils (10 g), Citrus sunki Hort.
ex Tanaka (10 g), Zingiber officinale Roscoe (3.3 g), Glycyrrhiza
uralensis Fisch (3.3 g), and Zizyphus jujuba var. inermis (Bunge) Rehder
(6.7 g). The KMP6 was dissolved in distilled water (DW) and
filtered with a 0.22 mm syringe filter. HS-PS granules were
prepared by dissolving in DW and being autoclaved for the
sterilization and kept at 4uC. HS-PS granules (3.5 g) contain some
excipients (1.7 g). We made the dose of HS-PS (2 mg/ml) two
times stronger than KMP6 (1 mg/ml). Hesperidin is a major
constituent of KMP6. KMP6 contained hesperidin of about
5.26 mg/g (data not shown).
Computational Method
Computer-aided docking simulation was performed by Surflex-
Dock (Tripos, St. Louis, MO). The molecular model for the
receptor protein, c-kit was obtained from the Protein Data Bank
(PDB id 2E9W) with further energy-minimization. The 3D
coordinates of each component were prepared by a molecular
sketch module. All molecular modeling work was conducted using
by a SYBYL X 1.1 package. To obtain an accurate binding mode
and affinity data, docking was conducted in the Geom mode of
Surfelx-Dock. A 6 A ˚ of an expanded search grid, a maximum of
20 conformations per fragment, and a maximum of 100 rotatable
bonds per molecule were used as general docking parameters. Spin
alignment was activated with a search density of 3 A ˚ and 12 spins
per alignment. The docked pose for each component with c-kit
was ranked according to Surflex-Dock Score.
Animals
The original stock of male Wistar rats weighing 200–300 g were
purchased from Dae-Han Experimental Animal Center (Taejeon,
Chungnam, South Korea). The animals were housed 5–10 per
cage in laminar air flow room maintained at 2261uC and relative
humidity of 55610% throughout the study.
Preparation of RPMCs
Rats were anesthetized with ether, and injected with 20 ml of
Tyrode buffer B (NaCl, glucose, NaHCO3, KCL, NaH2PO4)
containing 0.1% gelatin (Sigma) into the peritoneal cavity; the
abdomen was gently massaged for about 90 s. The peritoneal
cavity was carefully opened, and the fluid containing peritoneal
cells was aspirated with Pasteur pipette. Then the peritoneal cells
were sedimented at 150 x g for 10 min at room temperature and
resuspended in Tyrode buffer B. Mast cells were separated from
the major components of rat peritoneal cells (i.e., macrophages
and small lymphocytes). In brief, peritoneal cells suspended in
1 ml of Tyrode buffer B were layered onto 2 ml of 0.225 g/ml
metrizamide (density 1.120 g/ml; Sigma) and centrifuged at room
temperature for 15 min at 400 x g. The cells remaining at the
buffer-metrizamide interface were aspirated and discarded; the
cells in the pellet were washed and resuspended in 1 ml of Tyrode
buffer A (10 mM HEPES, 130 mM NaCl, 5 mM KCl, 1.4 mM
CaCl2, 1 mM MgCl2, 5.6 mM glucose, 0.1% bovine serum
albumin) containing calcium. Mast cell preparations were about
95% pure as assessed by toluidine blue staining. More than 97% of
the cells were viable as judged by the trypan blue uptake.
Cell culture
Purified RPMCs were maintained in a-MEM medium (Gibco
BRL, USA) with 10% fetal bovine serum (JRH BIOSCIENCE,
USA) at 37uC under 5% CO2 in air. RPMCs were preincubated
with KMP6 (0.01, 0.1, and 1 mg/ml), HS-PS (2 mg/ml),
hesperidin (0.01 mg/ml), or dexamethasone (100 nM) at 37uC
for 1 before the stimulation with SCF (50 ng/ml) for various times.
The cells were separated from the released TNF-a and ICAM-1
by centrifugation at 400 x g for 5 min at 4uC.
Assessment of cell viability and altered morphology
At time zero and subsequent time-points as indicated, cells were
counted in a haemocytometer and viability was assessed by trypan
blue dye exclusion. To assess the percentage of cells showing
characteristic morphological features, the cells were examined by
phase contrast microscopy. Photomicrography was done using Fuji
film at 6100 magnification.
Chemotaxis assay
SCF or the assay medium alone was applied into each well of
four-well culture plates. After 10-mm tissue culture inserts (Nalge
Nunc International, USA) were placed into each well, RPMCs
(500 ml) were added into each insert. The lower compartment of
the well was separated from the cell suspension in the upper
compartment with an 8 mm pore size polycarbonate membrane of
the culture inserts. RPMCs were incubated for 4 h at 37uCi na
humidified atmosphere flushed with 5% CO2 in air. Following
aspiration of nonadherent RPMCs in the upper compartment,
cells adherent to the upper surface of the membrane were removed
by scraping with a rubber blade. Migrated cells adherent to lower
surface of the membrane were fixed with methanol for 5 min and
stained with 0.5% toluidine blue. The membranes were mounted
on glass slides by routine histological methods. The total number
of mast cells that migrated across the membrane was counted
under a light microscope.
MTT assay
To test the cell viability, the MTT colorimetric assay was
performed. Briefly, Cells were incubated for 24 h after stimulation
in the presence or absence of KMP6, HS-PS, or hesperidin. 50 ml
of MTT solution (5 mg/ml) was added, and the cells were
incubated at 37uC for an additional 4 h. The crystallized MTT
was dissolved in DMSO and the absorbance measured at 540 nm
by a microplate reader.
F-actin formation in RPMCs treated with SCF
Detection of polymerized actin (F-actin) was determined in
RPMCs migrating toward the lower side of the membrane
according to the method described by Pteiffer and Oliver [17].
Briefly, RPMCs were preincubated with or without KMP6 (1 mg/
ml) or hesperidin (0.01 mg/ml) for 1 h and seeded into each
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culture plates. After stimulation with SCF for 1 h, RPMCs were
fixed with 3% paraformaldehyde/phosphate–buffered saline (PBS)
for 1 h at room temperature, washed 3 times with PBS, and
permeabilized with 1% Triton X-100/PBS for 15 min. The
preparations were stained for 30 min with F-actin specific probe,
1 U/ml NBD-phallacidin at room temperature. All specimens
were examined with a confocal laser-scanning microscope using an
argon ion laser, which is capable of excitation at 488 nm.
Enzyme-linked immunosorbent assay (ELISA) of TNF-a
and ICAM-1
Sandwich ELISA for TNF-a and ICAM-1 was carried out in
duplicate in 96-well ELISA plates (Nunc, USA) coated with each
of 100 ml aliquots of anti- TNF-a and ICAM-1 monoclonal
antibodies (R&D Systems, Minneapolis, MN, USA) at 1.0 mg/ml
in PBS at pH 7.4 and was incubated overnight at 4uC. The plates
were washed in PBS containing 0.05% tween-20 (Sigma, St.
Lousis, MO, USA) and blocked with PBS containing 1% BSA, 5%
sucrose and 0.05% NaN3 for 1 h. After additional washes, samples
were added and incubated at 37uC for 2 h. Recombinant TNF-a
and ICAM-1 were diluted and used as a standard. Serial dilutions
starting from 5 ng/ml were used to establish the standard curve.
After 2 h incubation at 37uC, the wells were washed and then each
of 0.2 mg/ml of biotinylated anti-TNF-a and ICAM-1 were added
and again incubated at 37uC for 2 h. After washing the wells,
Table 1. Docking scores of the ranked poses for complexes
between different components and the c-kit protein.
Component Docking Score Origin
Licuraside 7.93 Glycyrrhiza uralensis Fisch
Hesperidin 7.50 Citrus sunki Hort. ex Tanaka
Glycyrrhizin 7.44 Glycyrrhiza uralensis Fisch
Poncirin 7.15 Citrus sunki Hort. ex Tanaka
Liquiritin 6.92 Glycyrrhiza uralensis Fisch
Magnocurarine 6.48 Magnolia officinale Rehder et
Wils
Neoisoliquiritin 6.42 Glycyrrhiza uralensis Fisch
Honokiol 6.41 Magnolia officinale Rehder et
Wils
Oleanolic acid 6.31 Glycyrrhiza uralensis Fisch
Magnolol 5.51 Magnolia officinale Rehder et
Wils
Isoliquiritigenin 5.33 Glycyrrhiza uralensis Fisch
Eudesmol 5.22 Magnolia officinale Rehder et
Wils
Hisesol 4.70 Atractylodes japonica Koidzumi
Betulic acid 4.63 Glycyrrhiza uralensis Fisch
myo-Inositol 4.45 Citrus sunki Hort. ex Tanaka
Atractylenenolide III 4.13 Atractylodes japonica Koidzumi
Atractylenenolide I 4.07 Atractylodes japonica Koidzumi
Acetylatrsctylodinol 3.97 Atractylodes japonica Koidzumi
Coumarin 3.34 Glycyrrhiza uralensis Fisch
Atractylenenolide II 3.33 Atractylodes japonica Koidzumi
Atractylodin 2.68 Atractylodes japonica Koidzumi
d-Limonene 2.53 Citrus sunki Hort. ex Tanaka
doi:10.1371/journal.pone.0019528.t001
Figure 1. The top view (left) and side view (right) for
representative docked poses of the c-kit receptor protein with
(A) hesperidin and (B) stem cell factor.
doi:10.1371/journal.pone.0019528.g001
Figure 2. Inhibitory effect of KMP6 and hesperidin on SCF-
induced migration. RPMCs (3610
4) were treated with KMP6 (0.01, 0.1,
and 1 mg/ml), HS-PS (2 mg/ml), hesperidin (0.01 mg/ml), or dexameth-
asone (100 nM) for 1 h and then stimulated with SCF (50 ng/ml) for 4 h.
Migration of RPMCs was assessed by counting the number of RPMCs
through the polycarbonate membrane. Each datum represents the
mean 6 S.E.M. of duplicate determinations from three separate
experiments. * P,0.05, when compared with the medium alone;
** P,0.05, when compared with SCF. DEX, dexamethasone.
doi:10.1371/journal.pone.0019528.g002
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20 min at 37uC. Wells were again washed and ABTS substrate
was added. Color development was measured at 450 nm using an
automated microplate ELISA reader. A standard curve was run on
each assay plate using recombinant, TNF-a and ICAM-1 in serial
dilutions.
Western blot analysis
Cell extracts were prepared by detergent lysis procedure. Cells
were scraped, washed once with PBS, and resuspended in lysis
buffer. Samples were vortexed for lysis for a few seconds every 15
minutes at 4uC for 1 h and centrifuged at 15,000 x g for 5 min at
4uC. Supernatants were assayed. Samples were heated at 95uC for
Figure 3. Inhibitory effect of KMP6 and hesperidin on SCF-induced morphological alteration. RPMCs (3610
4) were treated with KMP6
(1 mg/ml), HS-PS (2 mg/ml), hesperidin (0.01 mg/ml), or dexamethasone (100 nM) for 1 h and then stimulated with SCF (50 ng/ml) for 4 days. Results
are representative of three independent experiments with duplicated samples (A). Morphological alteration was assessed by counting the number of
RMPCs for 4 days (B). Each datum represents the mean 6 S.E.M. of duplicate determinations from three separate experiments. * P,0.05, when
compared with the medium alone; ** P,0.05, when compared with SCF. Blank, unstimulated cells; DEX, dexamethasone.
doi:10.1371/journal.pone.0019528.g003
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15,000 x g for 5 min, 50 ml aliquots were resolved by 12% sodium
dodecyl sulfate polyacrylamide gel electrophoresis. Resolved
proteins were electrotransferred overnight to nitrocellulose mem-
branes in 25 mM Tris, pH 8.5, 200 mM glycine, 20% methanol
at 25 V. Blots were blocked for at least 2 h with 16PBS containing
0.05% tween 20 and 10% nonfat dry milk. The phosphated p38
antibody (1:500) was added and incubated for 1 h. Afterward,
nitrocellulose membrane was washed five times for 15 min with
PBST. For protein detection, blot was incubated with anti-mouse
secondary antibody conjugated with peroxidase for 40 min,
followed by ECL detection.
Statistical analysis of data
The experiments shown are a summary of the data from at
least-three experiments and are presented, as the mean 6 S.E.M.
Statistical evaluation of the results was performed by independent
t-test and ANOVA with Tukey post hoc test. The results were
considered significant at a value of P,0.05.
Results
Molecular docking of the components of KMP6 and c-kit
interaction
To predict the potential active component in the KMP6,
docking simulations were performed using molecular docking
software. Table 1 summarizes the final docking score of each
component bound to the SCF-binding site of the c-kit receptor
protein. The data for docking scores indicated that glycoside
compounds including licuraside, hesperidin, and glycyrrhizin were
the best components for the c-kit because they had the highest
docking score of all the molecules. Hesperidin is a major
component of KMP6. In this study, hesperidin was selected for
a further evaluation after considering its applicability and
attainability. The binding mode of the hesperin for the c-kit was
examined in order to compare it with that of SCF which is a
natural ligand for this receptor protein (Figure 1).
Effect of KMP6 and hesperidin on SCF-induced RPMCs
migration
TheeffectofKMP6andhesperidinonSCF-inducedcellmigration
was determined in a chemotaxis assay using a polycarbonated
membrane. SCF (50 ng/ml) was placed in the lower compartment,
and then the RPMCs were incubated for 4 h in the upper
compartment. SCF significantly increased the number of RPMCs,
which migrated toward the lower surface of the polycarbonate
membrane through 8-mmp o r e s( P,0.05, compared with the
medium alone without SCF). This migration was significantly
decreased by treatment of KMP6 (0.01, 0.1, and 1 mg/ml), HS-PS
(2 mg/ml), hesperidin (0.01 mg/ml), or dexamethasone (100 nM)
(P,0.05, Figure 2). A treatment of KMP6 resulted in a dose-
dependent inhibition of SCF-induced migration. The maximum
inhibition occurred at 1 mg/ml. Cell toxicity by KMP6, HS-PS,
hesperidin, or dexamethasone was not observed (data not shown).
Effect of KMP6 and hesperidin on SCF-induced
morphological changes
Next, we investigated the ability of KMP6 and hesperidin to
decrease the morphological change of RPMCs in the presence of
SCF. As shown in Figure 3, SCF (50 ng/ml) induced morpholog-
ical alterations in about 80% of the RPMCs after 4 days of culture.
However, the effect of SCF was mostly abolished by treatment
with KMP6 (1 mg/ml), HS-PS (2 mg/ml), hesperidin (0.01 mg/
ml), or dexamethasone (100 nM).
Effect of KMP6 and hesperidin on SCF-induced F-actin
formation
As F-actin formation is well known to be associated with cell
motility, we next examined the effect of KMP6 and hesperidin
Figure 4. Detection of F-actin in SCF-induced RPMCs with or without KMP6 and hesperidin. RPMCs (3610
4) were treated with KMP6
(1 mg/ml) or hesperidin (0.01 mg/ml) for 1 h and then stimulated with SCF (50 ng/ml) for 1 h. Confocal images of RPMCs were stained with NBD-
phallacidin. F-actin was visualized using a conforcal laser scanning microscope (A). RPMCs treated with SCF exhibited a high fluorescent intensity (B).
Results are representative of three independent experiments with duplicated samples. * P,0.05, when compared with the medium alone; ** P,0.05,
when compared with SCF. Blank, unstimualted cells.
doi:10.1371/journal.pone.0019528.g004
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that were passing through the pore toward SCF was stained
with NBD-phallacidin. Confocal laser scanning microscopic
analysis clearly demonstrated that the enhanced formation of F-
actin was induced by treatment with 50 ng/ml SCF, but it was
markedly blocked by treatment with KMP6 (1 mg/ml) or
hesperidin (0.01 mg/ml) (Figure 4A). F-actin levels were
obtained from single cell and evaluated as fluorescent intensity
(Figure 4B).
Effect of KMP6 and hesperidin on SCF-induced activation
of p38
To determine whether the inhibitory action of KMP6 and
hesperidin was related to p38 MAPK activation, cell lysates were
analyzed for phosphorylated-p38 by immunoblot using an
antibody that specifically recognized that phosphorylation form
of the protein. Previously, Sundstrom et al. reported that
activation of the p38 signaling pathways peaked at 5 to 10 min
[14], and the RPMCs were stimulated with SCF for 10 min. As
shown in Figure 5, the addition of 50 ng/ml SCF to RPMCs
induced phosphorylation of p38 MAPK. KMP6 (1 mg/ml), HS-
PS (2 mg/ml), hesperidin (0.01 mg/ml), dexamethasone
(100 nM), or SB203580 (20 mM, p38 inhibitor) reduced the levels
of phosphorylated-p38 (Figure 5A) in SCF-stimulated RPMCs.
The protein levels were quantitated by densitometry (Figure 5B,
Pharmacia Biotech, USA).
Effect of KMP6 and hesperidin on SCF-induced TNF-a and
ICAM-1 production
Finally, to determine whether KMP6 and hesperidin can
modulate SCF-induced TNF-a and ICAM-1 production from
RPMCs, the cells were treated with KMP6 (1 mg/ml), HS-PS
(2 mg/ml), hesperidin (0.01 mg/ml), or dexamethasone (100 nM)
for 1 h prior to stimulation with SCF for 24 h or 72 h. Culture
supernatants were assayed for TNF-a and ICAM-1 protein levels
by the ELISA method. As shown in Figure 6A and B, SCF
significantly enhanced TNF-a (1.0260.02 ng/ml, P,0.05) and
ICAM-1 (0.1860.04 ng/ml, P,0.05) production compared with
media control (0.0460.01 ng/ml for TNF-a and 0.0560.01 ng/
ml for ICAM-1). This induction was significantly inhibited by
treatment of KMP6 (1 mg/ml), HS-PS (2 mg/ml), hesperidin
(0.01 mg/ml), or dexamethasone (100 nM, P,0.05). Inhibition of
TNF-a and ICAM-1 production by treatment of KMP6 was about
88.9% and 33.1%, respectively.
Discussion
In the present study, we showed that KMP6 and hesperidin
inhibited SCF-dependent stimulatory effects on migration, mor-
phological alteration, and TNF-a and ICAM-1 production in
RPMCs. In addition, KMP6 and hesperidin inhibited SCF-
induced p38 MAPK activation.
Directed migration of mast cells towards a chemical gradient of
specific chemoattractants locally produced in inflamed tissues is
the first integrated event in the process of allergic and non-allergic
inflammatory responses [18,19]. The localization of mast cell
precursors to specific tissue sites and the accumulation of mast cells
within the given tissue at an inflammatory response were induced
by the chemotactic factor, SCF [1]. SCF stimulates specific
receptors, c-kit on the cell surface, that initiate several second
messenger cascades; this action results in a change in F-actin
distribution from azimuthal symmetry around the cell rim to
concentration at a particular region involved in migratory behavior
[20]. We previously reported that SCF induced morphological
alteration and migration of RPMC [21]. Morphological alteration
and migration of mast cells by SCF is an important step for the
participation in adhesion to tissue [21]. Previously, we also reported
that dexamethasone inhibits the migration and F-actin distribution
of RPMCs in the presence of recombinant SCF [21]. In this study,
we demonstrated that KMP6 and HS-PS inhibited SCF-induced
migration of RPMCs and distribution of F-actin. These results
including our findings suggest that KMP6 and HS-PS might
regulate the migratory process of mast cells following SCF
stimulation. Anti-inflammatory, antioxidant, and anti-cancer effects
ofhesperidin,amaincomponentofCitrusunshiu, havebeen reported
[22–24]. We reported for the first time that hesperidin reduced
SCF-induced mast cell migration and morphological alteration.
Therefore, we found that hesperidin is an active compound of
KMP6 on SCF-induced mast cell migration.
Binding of SCF to c-kit activates different intracellular signaling
components, including the p38 MAPK [25]. MAPK, p38
activation by SCF is of main importance for cell migration toward
SCF in general. Suppressing p38 MAPK signaling in mast cells
may be a useful tool to reduce mast cell numbers in inflammatory
conditions. As described above, KMP6 consists of 6 different
herbs. We previously reported that beta-eudesmol, a component of
Atractylodes rhizome inhibited p38 activation [26]. Other researchers
Figure 5. Inhibitory effect of KMP6 and hesperidin on SCF-
induced p38 activation. RPMCs (3610
6) were treated with KMP6
(1 mg/ml), HS-PS (2 mg/ml), hesperidin (0.01 mg/ml), dexamethasone
(100 nM), or SB203580 (20 mM) for 1 h and then stimulated with SCF
(50 ng/ml) for 10 min. Total protein was prepared and analyzed for
phosphorylated p38 MAPK by Western blotting as described in the
experimental procedures (A). Phosphorylated p-38 levels were quanti-
tated by densitometry (B). Results are representative of three
independent experiments with duplicated samples. * P,0.05, when
compared with the medium alone; ** P,0.05, when compared with
SCF. DEX, dexamethasone; SB, SB203580.
doi:10.1371/journal.pone.0019528.g005
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inhibited p38 activation [27]. We showed that p38 MAPK
activation and activity were blocked when RPMCs were
pretreated with KMP6, HS-PS, hesperidin, dexamethasone, or
SB203580. Therefore, we suggested that KMP6 reduced the mast
cell number via regulation of p38 activation in inflammatory
reactions.
TNF-a is constitutively expressed cytokine in mast cells and it is
considered a major initiator of inflammation [28]. TNF-a also
regulated expression of chemokines such as IL-8, MCP-1, and
RANTES. Mucosal inflammation is a feature of both bronchial
asthma and allergic rhinitis with evident tissue eosinophilia, mast
cells, eosinophils, and T-lymphocytes activation. The initial phase
of cell recruitment is the margination and adhesion of leucocytes to
the endothelium, prior to their transendothelial migration under a
directed chemotactic stimulus. This adhesion occurs through
specific ligand-receptor couplets involving leucocyte-endothelial
adhesion molecules. One of these cell adhesion molecules is
ICAM-1, an important early marker of immune activation and
response [29]. Choi et al. reported that hesperidin, a major
component of KMP6, inhibited expression of inflammatory
cytokines (IL-1beta, IL-6, IL-8, and TNF-a) [22]. Chang et al.
reported that glycyrrhetinic acid, a component of Glycyrrhizae radix,
inhibits ICAM-1 expression via blocking JNK and NF-kappaB
pathways in TNF-a-activated cells [30]. We demonstrated that
KMP6, HS-PS, and hesperidin inhibited SCF-induced TNF-a and
ICAM-1 production. These findings may contribute to under-
standing the anti-inflammatory effect of KMP6.
Virtual (database) screening (VS) of molecules promises to
accelerate the discovery of new drugs and reduce costs by
identifying molecules with high probabilities of binding to a target
receptor. The large amount of available protein X-ray crystal
structures, together with the development of more effective
homology modeling techniques, has led recently to a steep
increase in docking-based VS studies. This approach needs
computational fitting of molecules into a receptor active site using
advanced algorithms, followed by the scoring and ranking of these
molecules to identify potential leads. In this study, molecular
docking results suggested that glycosidic moiety of hesperidin was
tightly bound to c-kit in the same manner as the SCF with c-kit.
The glycosidc moiety of hesperdin plays a similar role in an a-
helical region of the SCF. Furthermore, the flavonoidic backbone
of the hesperidin gave an additional affinity with the receptor c-kit
protein with aromatic and hydrogen bonding interaction. This
ligand bound conformation and docking score of the hesperidin
with c-kit provide a molecular-level insight toward explaining its
biological efficacy. As described above, hesperidin was also known
as a regulator of various intracellular proteins. Taken together, we
can presuppose that hesperidin inhibits SCF-induced mast cell
migration through regulation of the activity of intracellular
proteins and prevention of SCF and c-kit interaction.
In conclusion, we identified a new anti-allergic effect of KMP6.
Our results suggest that KMP6 may be useful in the treatment of
SCF-mediated inflammatory diseases.
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Figure 6. Inhibitory effect of KMP6 and hesperidin on SCF-induced cytokine release from RPMCs. RPMCs (3610
5) were treated with
KMP6 (1 mg/ml), HS-PS (2 mg/ml), hesperidin (0.01 mg/ml), or dexamethasone (100 nM) for 1 h and then stimulated with SCF (50 ng/ml) for 24 h
(TNF-a) or 72 h (ICAM-1). TNF-a (A) and ICAM-1 (B) concentrations were measured from cell supernatants using the ELISA method. Each datum
represents the mean 6 S.E.M. of duplicate determinations from three independent experiments. * P,0.05, when compared with the medium alone,
** P,0.05, when compared with SCF. DEX, dexamethasone.
doi:10.1371/journal.pone.0019528.g006
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